Search research articles
Contact Us
Filters
Showing results (51-60 of 750) with videos related to
Page
of 75
Sort By:
RSC Advances
|
May 2, 2022
Application of a clustered countercurrent-flow micro-channel reactor in the preparation of KMnF<sub>3</sub> perovskite for asymmetric supercapacitors
Kun-Peng Cheng, Ren-Jie Gu, Li-Xiong Wen
Cellular & Molecular Immunology
|
July 8, 2025
Eliciting antitumor immunity via therapeutic cancer vaccines
Kun Peng, Xiaoxue Zhao, Yang-Xin Fu, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
November 2, 2010
Clinical immunogenicity specificity assessments: a platform evaluation
Kun Peng, Ketevan Siradze, Valerie Quarmby, et al.
Journal of Cancer
|
May 29, 2018
Circular RNA circ_HIPK3 is down-regulated and suppresses cell proliferation, migration and invasion in osteosarcoma
Ma Xiao-Long, Zhu Kun-Peng, Zhang Chun-Lin
European Journal of Preventive Cardiology
|
April 12, 2026
Lipoprotein apheresis for lowering Lp(a): the conceptual confusion between 'acute removal' and 'chronic control' may mislead clinical interpretation
Li-Bing Liang, Kun-Peng Li, Cai-Qin Wu
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 20, 2025
Retraction Notice to: LncRNA ODRUL Contributes to Osteosarcoma Progression through the miR-3182/MMP2 Axis
Kun-Peng Zhu, Xiao-Long Ma, Chun-Lin Zhang
Journal of Anesthesia
|
July 12, 2015
Videolaryngoscope for intubation during chest compression
Kun Peng Liu, Fu Shan Xue, Cheng Hui Li
Cancer Letters
|
March 22, 2017
Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2
Chun-Lin Zhang, Kun-Peng Zhu, Xiao-Long Ma
Chemical Society Reviews
|
April 4, 2023
Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses
Kun Peng, Yue Zheng, Wei Xia, et al.
Oncotarget
|
October 27, 2017
LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1
Zhu Kun-Peng, Ma Xiao-Long, Zhang Chun-Lin
Page
of 75
Search research articles
Search
Showing results (51-60 of 750) with videos related to
Sort By:
Page
of 75
RSC Advances
|
May 2, 2022
Application of a clustered countercurrent-flow micro-channel reactor in the preparation of KMnF<sub>3</sub> perovskite for asymmetric supercapacitors
Kun-Peng Cheng, Ren-Jie Gu, Li-Xiong Wen
Cellular & Molecular Immunology
|
July 8, 2025
Eliciting antitumor immunity via therapeutic cancer vaccines
Kun Peng, Xiaoxue Zhao, Yang-Xin Fu, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
November 2, 2010
Clinical immunogenicity specificity assessments: a platform evaluation
Kun Peng, Ketevan Siradze, Valerie Quarmby, et al.
Journal of Cancer
|
May 29, 2018
Circular RNA circ_HIPK3 is down-regulated and suppresses cell proliferation, migration and invasion in osteosarcoma
Ma Xiao-Long, Zhu Kun-Peng, Zhang Chun-Lin
European Journal of Preventive Cardiology
|
April 12, 2026
Lipoprotein apheresis for lowering Lp(a): the conceptual confusion between 'acute removal' and 'chronic control' may mislead clinical interpretation
Li-Bing Liang, Kun-Peng Li, Cai-Qin Wu
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 20, 2025
Retraction Notice to: LncRNA ODRUL Contributes to Osteosarcoma Progression through the miR-3182/MMP2 Axis
Kun-Peng Zhu, Xiao-Long Ma, Chun-Lin Zhang
Journal of Anesthesia
|
July 12, 2015
Videolaryngoscope for intubation during chest compression
Kun Peng Liu, Fu Shan Xue, Cheng Hui Li
Cancer Letters
|
March 22, 2017
Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2
Chun-Lin Zhang, Kun-Peng Zhu, Xiao-Long Ma
Chemical Society Reviews
|
April 4, 2023
Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses
Kun Peng, Yue Zheng, Wei Xia, et al.
Oncotarget
|
October 27, 2017
LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1
Zhu Kun-Peng, Ma Xiao-Long, Zhang Chun-Lin
Page
of 75